RxDoctor Payments DataLook up a doctor →

Douglas Denham

Family Medicine · San Antonio, TXNPI 1467533893

Payments from drug & device makers

$68,546,786in general payments, 2019–2025

Across 11,810 payments — averaging $5804.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$18.7M
  • Modernatx, Inc.$16.2M
  • Astrazeneca UK Limited$4.5M
  • Eli Lilly$3.9M
  • Janssen Research & Development, LLC$3.6M
  • Biontech SE$3.1M
  • plus $18.5M from 39 others
$87,699in research payments, 2019–2025

Across 19 payments — averaging $4615.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$81K
  • Pfizer$6K
  • Novo Nordisk AS$121
  • Gilead$78

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$68,546,786 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Other family medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →